{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/diabetes-type-2/diagnosis/diagnosis-in-children-young-people/","result":{"pageContext":{"chapter":{"id":"1a3a574b-4a8b-5631-afa1-71b1e679c80b","slug":"diagnosis-in-children-young-people","fullItemName":"Diagnosis in children and young people","depth":2,"htmlHeader":"<!-- begin field a21b714c-266c-4f9a-a0ed-f451326588ac --><h2>When should I suspect type 2 diabetes in a child or young person?</h2><!-- end field a21b714c-266c-4f9a-a0ed-f451326588ac -->","summary":"","htmlStringContent":"<!-- begin item ccae11df-28ae-4e3b-8e25-f5c08cf128c9 --><!-- begin field de4c3a17-99c9-41c3-aebf-18b0e211f13e --><ul><li><strong>Consider a diagnosis of type 2 diabetes if a child or young person presents with persistent hyperglycaemia that may be accompanied by clinical features.</strong><ul><li>Possible clinical features of type 2 diabetes include:<ul><li>Symptoms such as polydipsia, polyuria, nocturia or enuresis, blurred vision, unexplained weight loss, recurrent infections, and tiredness. Note: these may be mild or absent.</li><li>Behavioural changes such as reduced school performance and/or impaired growth.</li><li>Signs such as acanthosis nigricans (a skin condition causing dark pigmentation of skin folds, typically the axillae, groin, and neck), which suggests insulin resistance.</li><li>The presence of <a class=\"topic-reference internal-reference\" href=\"/topics/diabetes-type-2/background-information/risk-factors/\">risk factors</a>.</li></ul></li><li>Persistent hyperglycaemia is defined as:<ul><li>Fasting plasma glucose level of 7.0 mmol/L or more.</li><li>Random plasma glucose of 11.1 mmol/L or more in the presence of symptoms or signs of diabetes.</li><li>Note: do not use <a class=\"topic-reference internal-reference\" href=\"/topics/diabetes-type-2/diagnosis/diagnosis-in-adults/#interpreting-hba1c-results\">measurement of HbA1c</a> to make a diagnosis of type 2 diabetes in children.</li></ul></li><li>Be aware that a diagnosis of type 2 diabetes is more likely if there are:<ul><li>No additional features of type 1 diabetes. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a> for more information.</li><li>No clinical features of <a class=\"topic-reference internal-reference\" href=\"/topics/diabetes-type-2/background-information/definition/\">other types of diabetes</a>, such as monogenic diabetes or diabetes secondary to another condition or disease.</li></ul></li></ul></li><li><strong>If a diagnosis of type 2 diabetes is suspected in a child or young person:</strong><ul><li>Arrange immediate same-day referral to a multidisciplinary paediatric diabetes team to confirm the diagnosis and provide immediate care.</li></ul></li></ul><!-- end field de4c3a17-99c9-41c3-aebf-18b0e211f13e --><!-- end item ccae11df-28ae-4e3b-8e25-f5c08cf128c9 -->","topic":{"id":"4cff0b65-d29e-58db-b418-fcdb1897bd57","topicId":"dba8b2b1-8488-45e6-9329-463370bd9023","topicName":"Diabetes - type 2","slug":"diabetes-type-2","lastRevised":"Last revised in January 2021","chapters":[{"id":"ce93e6b6-8912-5b90-9c15-32bad09cd193","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8d3d821c-c56f-5a60-b009-95b1715d5a30","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"fd9d266b-7574-5ae2-bba8-a649a01dc340","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"40e53df7-3aa4-576e-b7a9-d85a43c83320","slug":"changes","fullItemName":"Changes"},{"id":"021a3bbf-b397-508a-89fc-9390fc999490","slug":"update","fullItemName":"Update"}]},{"id":"744742d1-ce8a-5be0-a598-932c5de9082e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f5554f3c-df7d-5d47-af73-8cc512e67ed3","slug":"goals","fullItemName":"Goals"},{"id":"411c8c8f-bfdc-52ae-84ef-e0973b0bde2f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0ae17253-4d38-5085-b166-aed4eb4776c6","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"526d37c4-a641-5eef-90a0-fbf8728df4d4","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"cd0c8c03-5408-5e58-8e95-67848862b20a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"16103129-20c2-589f-ab7b-287ae3cd6db8","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"52c6d376-183c-509a-b866-5f284378ada4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3df9be9e-2813-553a-9fba-c83b602b3519","slug":"definition","fullItemName":"Definition"},{"id":"992e9977-3edc-5908-9b93-3ccffb16d1bd","slug":"causes","fullItemName":"Causes"},{"id":"823e084d-d878-50ad-9ccc-21b5b2618273","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"e49f375e-b244-5536-9644-f50117e573cd","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9e28b175-c383-51dd-b999-d92f5eadac0c","slug":"prognosis","fullItemName":"Prognosis"},{"id":"f7eabf8c-8aab-5cc0-b9f5-c67e6d4992bf","slug":"complications","fullItemName":"Complications"}]},{"id":"c5223482-bcb9-5292-9da9-a311c0a2e2f6","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"324f22c7-6746-5065-a0e5-f536cc9b7b08","slug":"diagnosis-in-adults","fullItemName":"Diagnosis in adults"},{"id":"1a3a574b-4a8b-5631-afa1-71b1e679c80b","slug":"diagnosis-in-children-young-people","fullItemName":"Diagnosis in children and young people"},{"id":"6cd92df9-dfac-50e7-91bf-aa8a84abeb25","slug":"when-to-suspect-hyperglycaemic-emergencies-dka-hhs","fullItemName":"When to suspect hyperglycaemic emergencies (DKA and HHS)"},{"id":"441e294a-e6e2-51e2-a4ff-43c90bd062cb","slug":"when-to-suspect-hypoglycaemia","fullItemName":"When to suspect hypoglycaemia"}]},{"id":"82ac0366-3d17-50b1-aa1e-a3e99d6e5144","fullItemName":"Management","slug":"management","subChapters":[{"id":"08850dc1-fe0b-5c26-a333-c4cb006e5e75","slug":"management-adults","fullItemName":"Scenario: Management - adults"},{"id":"dfab96b2-5e91-57ff-bec0-fa00af42079e","slug":"management-children-young-people","fullItemName":"Scenario: Management - children and young people"}]},{"id":"1b4e6a82-89a8-5319-bf06-05194b98d82d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"74d00fac-f86f-57ad-babf-5d1fe1f9de16","slug":"metformin","fullItemName":"Metformin"},{"id":"72616639-7871-5c48-9532-fef54860cf16","slug":"dpp-4-inhibitors","fullItemName":"DPP-4 inhibitors"},{"id":"aa941789-8eb7-560d-8aa9-d295ec1ef445","slug":"pioglitazone","fullItemName":"Pioglitazone"},{"id":"8c669638-5b99-55a8-a887-f814f6b5fcda","slug":"sulfonylureas","fullItemName":"Sulfonylureas"},{"id":"60c24d46-ee19-572f-8edb-6c8825ae2e4c","slug":"sglt-2-inhibitors","fullItemName":"SGLT-2 inhibitors"},{"id":"d1fec183-3ce2-5a1a-8a1f-d311251169ed","slug":"glp-1-receptor-agonists","fullItemName":"GLP-1 receptor agonists"}]},{"id":"b20c2a35-6a9f-553f-a0ae-37ce10a454e1","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"02f494c5-26fc-568d-b011-fa06912e1b30","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a679ba5d-d00a-5885-93d4-254752ecc2be","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"73ffe0ed-8b83-5a6a-b466-3413fb4d962e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1e48f1e8-8da5-5805-808b-c23b6b74a24d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"12814e2d-5205-5714-a20b-3a35be729f4e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"16bc4fdb-b9af-5017-abab-b2da6db4889c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e694c0d9-6d5f-5969-82fa-6f4dcfb5baf7","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"c5223482-bcb9-5292-9da9-a311c0a2e2f6","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"c240149f-17ff-5b0a-9408-f7fced28cd04","slug":"basis-for-recommendation-047","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 01ed5522-da6f-49e5-b8bf-56d10bed4cae --><h3>Basis for recommendation</h3><!-- end field 01ed5522-da6f-49e5-b8bf-56d10bed4cae -->","summary":null,"htmlStringContent":"<!-- begin item 04749f27-b735-4a9c-aaa3-b74d2841620f --><!-- begin field 1bdfc640-c960-4549-9236-358ffb3ea00d --><p>The recommendations on diagnosis in children and young people are based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Diabetes (type 1 and type 2) in children and young people: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">NICE, 2020b</a>], the International Society for Pediatric and Adolescent Diabetes (ISPAD) clinical practice consensus guidelines <em>Type 2 diabetes mellitus in youth</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Zeitler, 2018</a>] and <em>Definition, epidemiology, and classification of diabetes in children and adolescents</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Mayer-Davis, 2018</a>], the World Health Organization (WHO) publication <em>Classification of diabetes mellitus 2019</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">WHO, 2019</a>], and expert opinion in a review article on youth-onset type 2 diabetes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Candler, 2018a</a>].</p><h4>When to consider type 2 diabetes</h4><ul><li>The information on the possible presenting symptoms of type 2 diabetes is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">NICE, 2020b</a>] and the ISPAD clinical practice consensus guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Mayer-Davis, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Zeitler, 2018</a>]. The information on the sign of acanthosis nigricans is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">NICE, 2020b</a>].</li><li>The information on the presence of risk factors is based on the WHO publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">WHO, 2019</a>] and the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">NICE, 2020b</a>].</li><li>The information on the definition of persistent hyperglycaemia is based on the WHO publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">WHO, 2019</a>], the ISPAD clinical practice consensus guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Mayer-Davis, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Zeitler, 2018</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Candler, 2018a</a>]. The ISPAD guidelines note that no diagnostic criteria have been specifically validated in children and young people and are therefore extrapolated from adult definitions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Zeitler, 2018</a>].</li><li>The recommendation that HbA1c should not be used to diagnose type 2 diabetes in children and young people is based on the ISPAD clinical practice consensus guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Mayer-Davis, 2018</a>] and expert opinion in a review article, which notes that the HbA1c cut-off used to diagnose type 2 diabetes in adults is not considered sufficiently accurate in children to make a diagnosis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Candler, 2018a</a>].</li></ul><h4>Arranging immediate same-day referral </h4><ul><li>The recommendation to arrange immediate paediatric diabetes team referral if type 2 diabetes is suspected is based on the ISPAD clinical practice consensus guidelines, which recommend prompt referral to a team with expertise in managing children with diabetes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Mayer-Davis, 2018</a>].<ul><li>It notes that waiting to confirm hyperglycaemia is unnecessary, and if ketones are present in blood or urine treatment is urgent, because ketoacidosis in children and young people can evolve rapidly.</li><li>In addition, specialist tests including diabetes-associated autoantibody titres and/or molecular genetic testing to differentiate between type 1, type 2, monogenic, and other types of diabetes may be needed, which have important implications for treatment and future education [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Mayer-Davis, 2018</a>]. This approach is supported by expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">Candler, 2018a</a>].</li><li>CKS notes that the NICE clinical guideline does not recommend the routine measurement of autoantibodies associated with type 1 diabetes at initial presentation to support a diagnosis of type 2 diabetes if the test is negative, however, these tests may be considered after initial presentation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diabetes-type-2/references/\">NICE, 2020b</a>].</li></ul></li></ul><!-- end field 1bdfc640-c960-4549-9236-358ffb3ea00d --><!-- end item 04749f27-b735-4a9c-aaa3-b74d2841620f -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}